𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic factors in patients with thick cutaneous melanoma (> 4 mm)

✍ Scribed by Elizabeth Zettersten; Richard W. Sagebiel; James R. Miller III; Sreedhar Tallapureddy; Stanley P. L. Leong; Mohammed Kashani-Sabet


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
122 KB
Volume
94
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND

The current study was conducted to examine the role of multiple clinical and histologic factors in the prognostic assessment of patients with thick primary melanoma (> 4 mm, classified as T4).

METHODS

A retrospective analysis was performed in 329 patients with T4 cutaneous melanomas who were seen at the University of California at San Francisco Melanoma Center between 1978 and 2000. Fourteen histopathologic features were recorded prospectively by a single dermatopathologist. In addition, 9 clinical factors were analyzed.

RESULTS

Several histologic factors were found to have a significant impact on the survival of patients with T4 melanoma. On univariate analysis, tumor thickness, ulceration, mitotic rate, microsatellites, vascular involvement, and histogenetic type of the primary tumor all were found to have a significant impact on the overall survival rate. Regional lymph node involvement reduced the overall survival of T4 patients dramatically. The 5‐year overall survival of patients with lymph node‐negative T4 disease was 61%, compared with 30% for those with lymph node‐positive disease. When lymph node status was taken into account, tumor thickness, vascular involvement, and ulceration all remained independent predictors of overall survival on multivariate Cox regression analysis. Neither age, gender, nor anatomic location appeared to affect the recurrence‐free or overall survival rates.

CONCLUSIONS

Patients with thick primary cutaneous melanomas (> 4 mm) comprise a heterogeneous group. The presence or absence of lymph node involvement, vascular involvement, and ulceration appears to result in significantly divergent overall survival rates in this patient cohort. Consideration of these factors has important implications in the management of patients with T4 melanoma. Cancer 2002;94:1049–56. Β© 2002 American Cancer Society.

DOI 10.1002/cncr.10326


πŸ“œ SIMILAR VOLUMES


Molecular detection of circulating tumor
✍ Simone Mocellin; Paolo Del Fiore; Laura Guarnieri; Romano Scalerta; Mirto Folett πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 87 KB πŸ‘ 1 views

## Abstract Detection of circulating tumor cells (CTCs) might improve current staging procedures by identifying a subgroup of patients with minimal residual disease and thus a higher risk of disease recurrence. Forty patients with β‰₯2‐mm‐thick cutaneous melanoma with or without lymph node metastasis